RU2015118217A - Способ кристаллизации трициклических индольных производных - Google Patents

Способ кристаллизации трициклических индольных производных Download PDF

Info

Publication number
RU2015118217A
RU2015118217A RU2015118217A RU2015118217A RU2015118217A RU 2015118217 A RU2015118217 A RU 2015118217A RU 2015118217 A RU2015118217 A RU 2015118217A RU 2015118217 A RU2015118217 A RU 2015118217A RU 2015118217 A RU2015118217 A RU 2015118217A
Authority
RU
Russia
Prior art keywords
formula
compound
hydrogen
composition according
alkyl
Prior art date
Application number
RU2015118217A
Other languages
English (en)
Russian (ru)
Inventor
Сондре НИЛЬСЕН
Сринат Баладжи Араликатти Прахладачар БАЛАДЖИ
Умамахешвар П. МОККАПАТИ
МОХАМЕД Афсал Мохаммед КАДАВИЛППАРАМПУ
Original Assignee
ДжиИ ХЕЛТКЕР ЛИМИТЕД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1300647.3A external-priority patent/GB201300647D0/en
Application filed by ДжиИ ХЕЛТКЕР ЛИМИТЕД filed Critical ДжиИ ХЕЛТКЕР ЛИМИТЕД
Publication of RU2015118217A publication Critical patent/RU2015118217A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
RU2015118217A 2012-11-30 2013-11-28 Способ кристаллизации трициклических индольных производных RU2015118217A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN3689DE2012 2012-11-30
IN3689/DEL/2012 2012-11-30
GBGB1300647.3A GB201300647D0 (en) 2013-01-15 2013-01-15 Crystallization
GB1300647.3 2013-01-15
PCT/EP2013/074986 WO2014083113A1 (en) 2012-11-30 2013-11-28 Crystallization process of tricyclic indole derivatives

Publications (1)

Publication Number Publication Date
RU2015118217A true RU2015118217A (ru) 2017-01-11

Family

ID=54266915

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015118217A RU2015118217A (ru) 2012-11-30 2013-11-28 Способ кристаллизации трициклических индольных производных

Country Status (12)

Country Link
US (1) US10709798B2 (cg-RX-API-DMAC7.html)
EP (1) EP2943195A1 (cg-RX-API-DMAC7.html)
JP (1) JP6280560B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150088802A (cg-RX-API-DMAC7.html)
CN (2) CN104837489A (cg-RX-API-DMAC7.html)
AU (1) AU2013351152A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015012138A2 (cg-RX-API-DMAC7.html)
CA (1) CA2892485A1 (cg-RX-API-DMAC7.html)
IN (1) IN2015DN03978A (cg-RX-API-DMAC7.html)
MX (1) MX2015006871A (cg-RX-API-DMAC7.html)
RU (1) RU2015118217A (cg-RX-API-DMAC7.html)
WO (1) WO2014083113A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных
US20160144477A1 (en) * 2014-11-21 2016-05-26 Diane Scott Coated compressive subpad for chemical mechanical polishing

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177440B1 (en) * 1996-10-30 2001-01-23 Eli Lilly And Company Substituted tricyclics
JP2001522884A (ja) 1997-11-14 2001-11-20 イーライ・リリー・アンド・カンパニー アルツハイマー病の処置方法
DZ2769A1 (fr) 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
JP2005527464A (ja) 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしてのシクロヘプタBインドール誘導体
JP2005527466A (ja) 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしてのシクロヘプトBインドール誘導体
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives
CN102834379B (zh) 2010-03-26 2014-12-24 通用电气健康护理有限公司 作为pbr配体的三环吲哚衍生物
GB201016038D0 (en) 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
GB201021263D0 (en) 2010-12-15 2011-01-26 Ge Healthcare Ltd Solid phase extraction method
US9220795B2 (en) * 2011-09-22 2015-12-29 Ge Healthcare Limited Indole derivatives
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных

Also Published As

Publication number Publication date
MX2015006871A (es) 2015-09-16
CN104837489A (zh) 2015-08-12
IN2015DN03978A (cg-RX-API-DMAC7.html) 2015-10-02
US20150335766A1 (en) 2015-11-26
JP2016507477A (ja) 2016-03-10
CN111362863A (zh) 2020-07-03
AU2013351152A1 (en) 2015-05-21
BR112015012138A2 (pt) 2017-07-11
EP2943195A1 (en) 2015-11-18
US10709798B2 (en) 2020-07-14
CA2892485A1 (en) 2014-06-05
JP6280560B2 (ja) 2018-02-14
WO2014083113A1 (en) 2014-06-05
KR20150088802A (ko) 2015-08-03

Similar Documents

Publication Publication Date Title
ES2910108T3 (es) Inhibidores de la histona metiltransferasa
EP3894392A1 (en) Compositions and methods for the treatment of cancer
DK3102577T3 (en) QUINOLONDERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS
CA2958625C (en) Crystal of pyrrole derivative and method for producing the same
RU2013153388A (ru) Способы применения активаторов пируваткиназы
WO2020155931A1 (zh) 一种jak抑制剂及其制备方法
ES2952770T3 (es) Formas de estado sólido de apalutamida
RU2013106754A (ru) Производное фталазинонкетона, способ его получения и его фармацевтическое применение
RU2010129910A (ru) 8-анилиноимидазопиридины и способы их использования
RU2010136050A (ru) 2-аминохинолиновые производные для использования в качестве ингибиторов секретазы (васе)
RU2010103160A (ru) ПРОИЗВОДНЫЕ 2-[(2-{ФЕНИЛАМИНО}-1Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)АМИНО]БЕНЗАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ IGF-1R ДЛЯ ЛЕЧЕНИЯ РАКА
RU2009113668A (ru) Производные аденозина как агонисты рецептора a2a
JP2018513832A5 (cg-RX-API-DMAC7.html)
RU2011140724A (ru) Способ модификации гиалуроновой кислоты с помощью комплекса (о-ацил-о'-алкилкарбонат - замещенный пиридин)
RU2011138850A (ru) Трициклические индольные производные в качестве лигандов pbr
ES3016407T3 (en) Tricyclic compounds as histone methyl-transferase inhibitors
JP2013520443A5 (cg-RX-API-DMAC7.html)
EP3416963B1 (en) Histone methyltransferase inhibitors
JP2009507108A5 (cg-RX-API-DMAC7.html)
RU2013111163A (ru) Способ in vivo визуализации рака
RU2011108663A (ru) Способы получения метилового эфира 4-оксооктагидроиндол-1-карбоновой кислоты и ее производные
RU2013118021A (ru) Способы и композиции для лечения сахарного диабета и дислипидемии
BR102016024814A2 (pt) composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
JP7008339B2 (ja) ペプチダーゼ活性検出用赤色蛍光プローブ
JP2016507477A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20161129